Intuitive Surgical, Inc.
NASDAQIntuitive Surgical reports Q2 results on July 16 with the Street broadly bullish but meaningfully more cautious on valuation than it was three months ago. The most telling pre-earnings signal is the wave of target-price reductions arriving in the days immediately before the print. TD Cowen cut its target to $520 from $585 on July 13, the same day RBC Capital trimmed from $650 to…
ISRG cost to borrow surges to 0.61%, jumping 141% in one week as short interest climbs 16% to 2.1% of float.
Snapshot as of 7 Aug 2026
A new long-form analysis for ISRG this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumIntuitive Surgical reports Q2 results on July 16 with the Street broadly bullish but meaningfully more cautious on valuation than it was three months ago. The most telling pre-earnings signal is the wave of…
Intuitive Surgical has shed nearly 8% over the past week, pulling back to $402.30, the lowest print in months — yet options traders have quietly moved to their most call-heavy stance in a year. The setup is a clean…
Intuitive Surgical enters its Q1 results tonight carrying a 6% weekly loss and a wave of freshly cut price targets — yet the analysts who trimmed are, almost to a firm, keeping their buy-equivalent ratings intact. The…
Intuitive Surgical reports Q1 2026 results on April 30, and the dominant story is a Street that remains broadly constructive even after trimming its ambitions. Analyst activity in the past two weeks has run almost…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ISRG — free to start on ORTEX.
Sign up for free →Open ISRG on ORTEX